In Partnership with:

Richmond Times-Dispatch

Cancer

28798 Stories, most recent news story added 55 seconds ago

Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute

Marketwire - Tue Nov 10, 8:49 am ET

HALIFAX, NOVA SCOTIA--(Marketwire - Nov. 10, 2009) - Immunovaccine Inc. (TSX VENTURE:IMV) , a vaccine development company, has signed a collaborative agreement with the National Cancer Institute (NCI) in Maryland, USA. The research collaboration involves formulating NCI's cancer vaccine antigens in DepoVaxT, Immunovaccine's vaccine enhancement system. "NCI is a world leader in the study of ...

Most-Blogged About